Home>Cancer Center>  Clinical Trials at Phoebe: Active List

Active List of Clinical Trials at Phoebe

Clinical trials are research studies in which people help doctors and researchers find ways to improve health care. Each study tries to answer scientific questions and to find better ways to prevent, diagnose, or treat disease.

We are currently running several clinical trials for various types of cancer in cooperation with a number of organizations that sponsor our trials. These include the Southwest Oncology Group, Sarah Cannon and National Surgical Adjuvant Breast and Bowel Project. Our trials are monitored by a committee of doctors, nurses and local community leaders called an Institutional Review Board (IRB) to ensure that participants' rights are protected and FDA mandates are met.

The following clinical trials are currently active at the Phoebe Cancer Center. Select a criteria to learn more about that particular clinical trial.


 

Breast Cancer (Neoadjuvant, HER2 Negative)

Criteria: Neoadjuvant, Phase III

Description: This study is looking at the use of chemotherapy before surgery in certain breast cancer patients. For further information, please click here.
 
Breast Cancer (Neoadjuvant, HER2 Positive)
 
Criteria: Neoadjuvant, Phase III
 
Description: This study is looking at the use of chemotherapy before surgery in certain breast cancer patients. For further information, please click here.
 
Breast Cancer (Early Stage, Post-Treatment)
 
Criteria: Post-Treatment, Phase III
 
Description: A study investigating the use of continued therapy after completion of Trastuzumab (Herceptin) treatment in preventing the recurrence of breast cancer. For further information, please click here.
 
Breast Cancer (HER2 Negative, Node Negative)
 
Criteria: Adjuvant, Phase III
 
Description: A study investigating the use of continued therapy after completion of Trastuzumab (Herceptin) treatment in preventing the recurrence of breast cancer. For further information, please click here.

Breast Cancer (Adjuvant, HER2 Positive)
 
Criteria: Adjuvant, Phase III
 
Description: This study incorporates the use of the ONCOTYPE DX genetic assay to determine the best course of treatment for breast cancer patients. For further information, please click here.

Breast (Adjuvant, HER2 Negative)

Criteria: Adjuvant, Phase III

Description: This study is looking at the use of chemotherapy after surgery in certain breast cancer patients. For further information, please click here.

Breast Cancer (DCIS)

Criteria: DCIS removed by Lumpectomy

Description: This study is looking at the use of chemotherapy combined with standard radiation therapy for the post-operative treatment of DCIS following lumpectomy. For further information, please click here.

 

 

Stage II Colon Cancer

Criteria: Adjuvant, Phase III

Description: This study is looking at the use of chemotherapy after surgery in Stage II colon cancer patients. For further information, please click here.

Non-Metastatic Rectal Cancer

Criteria: Neoadjuvant, Phase III
 
Description: This study is comparing two types of radiation and chemotherapy in patients with rectal cancer before surgery. For further information, please click here.
 
Metastatic Colon or Rectal Cancer
 
Criteria: Metastatic, Phase III
 
Description: A study investigating the use of chemotherapy in the treatment of metastatic cancer of the colon or rectum. For further information, please click here.

Gastrointestinal Stromal Tumor (GIST)
 
Criteria: Observational, Phase IV Study
 
Description: This study is following patients being treated for gastrointestinal stromal tumor. For further information, please click here.
 

 
 
Chemo Induced Anemia in Non-Small Cell Lung Cancer (NSCLC)

Criteria: Supportive care for patients with NSCLC, Phase III Study

Description: This study is investigating the treatment of chemotherapy induced anemia in patients receiving treatment for advanced or metastatic NSCLC. For further information, please click here.
 
Non-Metastatic (Stage IB – IIIA) Non-Small Cell Lung Cancer (NSCLC)
 
Criteria: Adjuvant, Phase III Study
 
Description: This study is investigating the use of chemotherapy in lung cancer patients following cancer. For further information, please click here.
 
Metastatic Non-Small Cell Lung Cancer (NSCLC)
 
Criteria: Stage IV, metastatic Non-Small Cell Lung Cancer, Phase III Study

Description: This study is comparing standard chemotherapy with the investigational treatment for metastatic NSCLC. For further information, please click here.

 

 
 
Renal Cell Cancer following Resection

Criteria: Adjuvant, Phase III Study

Description: This study is investigating the use of chemotherapy in patients with renal cell (kidney) cancer following surgery. For further information, please click here.
 

 

Multiple Myeloma (MM)

Criteria: Patients Registry for Treatment of Multiple Myeloma

Description: This registry study is tracking the standard treatments used by physicians for patients diagnosed with Multiple Myeloma.

Multiple Myeloma (MM)
 
Criteria: Newly Diagnosed MM, Phase III Study
 
Description: This study is investigating the use of chemotherapy in newly diagnosed MM. For further information, please click here.

Thrombocytopenia in Myelodysplastic Syndrome (MDS)
 
Criteria: Supportive Care for patients with MDS, Phase II Study
 
Description: This is a study investigating the treatment of thrombocytopenia in patients with MDS. For further information, please click here.
 

 
  • HER2 Positive Locally Recurrent or Metastatic Breast Cancer

 


For more information about clinical trials, please call the research department at (229) 312-0405.